Showing results (5501-5510 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 5, 2013
Clostridium difficile infection in children with inflammatory bowel disease: current evidenceAleksandra Banaszkiewicz, Hanna PituchCurrent Pharmaceutical Design|November 5, 2013
Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistanceAlexander A Nijevitch, Bulat Idrisov, Elsa N Akhmadeeva, et al.Current Pharmaceutical Design|November 5, 2013
Current and future insights in H. pylori eradication regimens: the need of tailoring therapyVasilios Papastergiou, Sotirios D Georgopoulos, Stylianos KaratapanisCurrent Pharmaceutical Design|March 15, 2021
The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A MetaanalysisHaibo Hu, Junjie Wang, Xi Li, et al.Current Pharmaceutical Design|March 15, 2021
Tocilizumab: From Rheumatic Diseases to COVID-19Alberto Raiteri, Fabio Piscaglia, Alessandro Granito, et al.Current Pharmaceutical Design|March 22, 2021
Tumor-Associated Macrophages as Potential Targets for Anti-Cancer Activity of Marine Invertebrate-Derived CompoundsLyudmila S Dolmatova, Igor Y DolmatovCurrent Pharmaceutical Design|September 5, 2022
Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung CancerXiongye Xu, Yanli Qiu, Simin Chen, et al.Current Pharmaceutical Design|December 13, 2021
H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic ComplicationsLeiqi Zhu, Yuanyang Li, Fangqi Xia, et al.Current Pharmaceutical Design|November 12, 2021
Anticoagulation Treatment in Venous Thromboembolism: Options and Optimal DurationStavrianna Diavati, Marios Sagris, Dimitrios Terentes-Printzios, et al.Current Pharmaceutical Design|November 25, 2021
Role of Lipopolysaccharides in Potential Applications of Nanocarrier SystemsPravin Shende, Shubham GuptaPageof 1,008